The pathophysiological mechanism of the disorder includes the development of maternal hyperglycemia due to inadequate insulin secretion, typically accompanied by insulin resistance during the second or third trimester of pregnancy [7,8,9]. This evidence concerns the gene INS and Hyperglycemia.